Therapy for acute pelvic inflammatory disease: A critique of recent treatment trials

Recent approaches to determine optimal antimicrobial treatment for acute pelvic inflammatory disease are reviewed. From this review, it is suggested that in future studies a randomized study design, with controls for known factors which influence prognosis, and a uniform objective scoring system for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of obstetrics and gynecology 1984-02, Vol.148 (3), p.235-240
1. Verfasser: Brunham, R.C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 240
container_issue 3
container_start_page 235
container_title American journal of obstetrics and gynecology
container_volume 148
creator Brunham, R.C.
description Recent approaches to determine optimal antimicrobial treatment for acute pelvic inflammatory disease are reviewed. From this review, it is suggested that in future studies a randomized study design, with controls for known factors which influence prognosis, and a uniform objective scoring system for monitoring clinical response be used and long-term evaluation of tubal function be performed. Such studies are urgently needed if optimal therapy for pelvic inflammatory disease is to be defined.
doi_str_mv 10.1016/S0002-9378(84)80061-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80953820</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002937884800617</els_id><sourcerecordid>13996561</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-eb3f52ff7fed7db1f786950fc300463c7c8754915e7f2fa42d18296b3dc5f3d43</originalsourceid><addsrcrecordid>eNqFkEtrWzEQRkVoSB03PyGgRSnt4iZ6XT26CcE0bSCQRdy1kKURVbkPV5IN_ve9jo23Xs2IOaP5OAjdUnJHCZX3b4QQ1hiu9FctvmlCJG3UBZpRYlQjtdQf0OyEfETXpfzdP5lhV-hKcik0UTO0XP6B7NY7HMeMnd9UwGvotsnjNMTO9b2rY97hkAq4At_xI_Y51fRvA3iMOIOHoeKawdX-0CXXlU_oMk4Fbo51jn4__VgufjUvrz-fF48vjReM1AZWPLYsRhUhqLCiUWlpWhI9J0RI7pXXqhWGtqAii06wQDUzcsWDbyMPgs_Rl8O_6zxOiUq1fSoeus4NMG6K1cS0XDNyFqTcGNlKOoHtAfR5LCVDtOucepd3lhK7127ftdu9U6uFfddu1bR3ezywWfUQTltHz9P883HuinddzG7wqZwwI9R0f5_z4YDBZG2bINviEwweQppUVxvGdCbIf0-Hnus</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>13996561</pqid></control><display><type>article</type><title>Therapy for acute pelvic inflammatory disease: A critique of recent treatment trials</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Brunham, R.C.</creator><creatorcontrib>Brunham, R.C.</creatorcontrib><description>Recent approaches to determine optimal antimicrobial treatment for acute pelvic inflammatory disease are reviewed. From this review, it is suggested that in future studies a randomized study design, with controls for known factors which influence prognosis, and a uniform objective scoring system for monitoring clinical response be used and long-term evaluation of tubal function be performed. Such studies are urgently needed if optimal therapy for pelvic inflammatory disease is to be defined.</description><identifier>ISSN: 0002-9378</identifier><identifier>EISSN: 1097-6868</identifier><identifier>DOI: 10.1016/S0002-9378(84)80061-7</identifier><identifier>PMID: 6364807</identifier><identifier>CODEN: AJOGAH</identifier><language>eng</language><publisher>Philadelphia, PA: Elsevier Inc</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Biological and medical sciences ; Clinical Trials as Topic ; Female ; Genital system. Reproduction ; Humans ; Intrauterine Devices - statistics &amp; numerical data ; Medical sciences ; Pelvic Inflammatory Disease - drug therapy ; Pelvic Inflammatory Disease - microbiology ; Pharmacology. Drug treatments ; Sexual Abstinence</subject><ispartof>American journal of obstetrics and gynecology, 1984-02, Vol.148 (3), p.235-240</ispartof><rights>1984 Mosby</rights><rights>1984 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-eb3f52ff7fed7db1f786950fc300463c7c8754915e7f2fa42d18296b3dc5f3d43</citedby><cites>FETCH-LOGICAL-c420t-eb3f52ff7fed7db1f786950fc300463c7c8754915e7f2fa42d18296b3dc5f3d43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002937884800617$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=9479650$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6364807$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brunham, R.C.</creatorcontrib><title>Therapy for acute pelvic inflammatory disease: A critique of recent treatment trials</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><description>Recent approaches to determine optimal antimicrobial treatment for acute pelvic inflammatory disease are reviewed. From this review, it is suggested that in future studies a randomized study design, with controls for known factors which influence prognosis, and a uniform objective scoring system for monitoring clinical response be used and long-term evaluation of tubal function be performed. Such studies are urgently needed if optimal therapy for pelvic inflammatory disease is to be defined.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Clinical Trials as Topic</subject><subject>Female</subject><subject>Genital system. Reproduction</subject><subject>Humans</subject><subject>Intrauterine Devices - statistics &amp; numerical data</subject><subject>Medical sciences</subject><subject>Pelvic Inflammatory Disease - drug therapy</subject><subject>Pelvic Inflammatory Disease - microbiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Sexual Abstinence</subject><issn>0002-9378</issn><issn>1097-6868</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtrWzEQRkVoSB03PyGgRSnt4iZ6XT26CcE0bSCQRdy1kKURVbkPV5IN_ve9jo23Xs2IOaP5OAjdUnJHCZX3b4QQ1hiu9FctvmlCJG3UBZpRYlQjtdQf0OyEfETXpfzdP5lhV-hKcik0UTO0XP6B7NY7HMeMnd9UwGvotsnjNMTO9b2rY97hkAq4At_xI_Y51fRvA3iMOIOHoeKawdX-0CXXlU_oMk4Fbo51jn4__VgufjUvrz-fF48vjReM1AZWPLYsRhUhqLCiUWlpWhI9J0RI7pXXqhWGtqAii06wQDUzcsWDbyMPgs_Rl8O_6zxOiUq1fSoeus4NMG6K1cS0XDNyFqTcGNlKOoHtAfR5LCVDtOucepd3lhK7127ftdu9U6uFfddu1bR3ezywWfUQTltHz9P883HuinddzG7wqZwwI9R0f5_z4YDBZG2bINviEwweQppUVxvGdCbIf0-Hnus</recordid><startdate>19840201</startdate><enddate>19840201</enddate><creator>Brunham, R.C.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>19840201</creationdate><title>Therapy for acute pelvic inflammatory disease: A critique of recent treatment trials</title><author>Brunham, R.C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-eb3f52ff7fed7db1f786950fc300463c7c8754915e7f2fa42d18296b3dc5f3d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Clinical Trials as Topic</topic><topic>Female</topic><topic>Genital system. Reproduction</topic><topic>Humans</topic><topic>Intrauterine Devices - statistics &amp; numerical data</topic><topic>Medical sciences</topic><topic>Pelvic Inflammatory Disease - drug therapy</topic><topic>Pelvic Inflammatory Disease - microbiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Sexual Abstinence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brunham, R.C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brunham, R.C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapy for acute pelvic inflammatory disease: A critique of recent treatment trials</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>1984-02-01</date><risdate>1984</risdate><volume>148</volume><issue>3</issue><spage>235</spage><epage>240</epage><pages>235-240</pages><issn>0002-9378</issn><eissn>1097-6868</eissn><coden>AJOGAH</coden><abstract>Recent approaches to determine optimal antimicrobial treatment for acute pelvic inflammatory disease are reviewed. From this review, it is suggested that in future studies a randomized study design, with controls for known factors which influence prognosis, and a uniform objective scoring system for monitoring clinical response be used and long-term evaluation of tubal function be performed. Such studies are urgently needed if optimal therapy for pelvic inflammatory disease is to be defined.</abstract><cop>Philadelphia, PA</cop><pub>Elsevier Inc</pub><pmid>6364807</pmid><doi>10.1016/S0002-9378(84)80061-7</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9378
ispartof American journal of obstetrics and gynecology, 1984-02, Vol.148 (3), p.235-240
issn 0002-9378
1097-6868
language eng
recordid cdi_proquest_miscellaneous_80953820
source MEDLINE; Elsevier ScienceDirect Journals
subjects Anti-Bacterial Agents - therapeutic use
Biological and medical sciences
Clinical Trials as Topic
Female
Genital system. Reproduction
Humans
Intrauterine Devices - statistics & numerical data
Medical sciences
Pelvic Inflammatory Disease - drug therapy
Pelvic Inflammatory Disease - microbiology
Pharmacology. Drug treatments
Sexual Abstinence
title Therapy for acute pelvic inflammatory disease: A critique of recent treatment trials
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T03%3A25%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapy%20for%20acute%20pelvic%20inflammatory%20disease:%20A%20critique%20of%20recent%20treatment%20trials&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=Brunham,%20R.C.&rft.date=1984-02-01&rft.volume=148&rft.issue=3&rft.spage=235&rft.epage=240&rft.pages=235-240&rft.issn=0002-9378&rft.eissn=1097-6868&rft.coden=AJOGAH&rft_id=info:doi/10.1016/S0002-9378(84)80061-7&rft_dat=%3Cproquest_cross%3E13996561%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=13996561&rft_id=info:pmid/6364807&rft_els_id=S0002937884800617&rfr_iscdi=true